Neurodevelopmental Outcomes of a Cohort of Children with Tuberous Sclerosis Complex with Epileptic Spasms

Lokesh Saini1, Swetlana Mukherjee2, Pradeep Kumar Gunasekaran1

  • 1Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.

Neuropediatrics
|June 28, 2023
PubMed

Insights

Children with tuberous sclerosis complex (TSC) and epileptic spasms frequently experience neurodevelopmental disorders like autism spectrum disorder (ASD) and intellectual disability (ID). Early identification and intervention are crucial for managing these complex conditions.

Area of Science:

  • Pediatric Neurology
  • Neurodevelopmental Disorders
  • Genetics

Background:

  • Tuberous sclerosis complex (TSC) is a genetic disorder associated with various neurological complications.
  • Epileptic spasms in TSC are often linked to significant neurodevelopmental challenges.
  • Underdiagnosis of neurodevelopmental outcomes in TSC with spasms contributes to morbidity.

Purpose of the Study:

  • To investigate the prevalence of neurodevelopmental disorders in children with TSC and a history of epileptic spasms.
  • To assess the spectrum of conditions including autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), and intellectual disability (ID).
  • To evaluate behavioral disorders using the Childhood Psychopathology Measurement Schedule (CPMS).

Main Methods:

  • A cross-sectional study conducted over 18 months at a pediatric tertiary care hospital.
  • Inclusion of 30 children diagnosed with TSC and a history of epileptic spasms.
  • Assessment using DSM-5 criteria for ASD, ADHD, ID/GDD, and CPMS for behavioral disorders.

Main Results:

  • A high proportion of children exhibited neurodevelopmental disorders: 50% had ID/GDD, 13.3% had ASD and ID/GDD, 10% had ADHD and ID/GDD, and 6.7% had ADHD only.
  • The median IQ/DQ score was 60.5, indicating significant cognitive impairment in many.
  • Nearly half of the children showed behavioral abnormalities, and seizure types varied, with some evolving into Lennox-Gastaut syndrome.

Conclusions:

  • Children with TSC and epileptic spasms have a high burden of neurodevelopmental disorders, including ASD, ADHD, and ID/GDD.
  • These comorbidities significantly impact long-term outcomes, even after spasm resolution.
  • This pilot study highlights the need for comprehensive neurodevelopmental screening and management in this population.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
228
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
439
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
351